Yearly Archives: 2013
Commercial Eyes is moving!
Commercial Eyes has announced that it is moving its head office to the heart of Melbourne – 500 Collins Street. Continue reading
Budget 2013 – A Bland Budget
On Tuesday 14th May, Treasurer Wayne Swan delivered what many have called a ‘safe’ budget. Opting not to use his time to outline a range of pre-election sweeteners, the government chose to defend its deficit position in a bland budget that focussed on Labor’s two legacy items – Gonski and the NDIS. Continue reading
Budget 2013 – A changing PBS operating environment
For many Eye Spy readers, hearing no price related changes to the PBS was the best possible outcome of the 2013 Budget. A momentary sigh of relief, but upon closer inspection we see that the operating environment for medicines is changing in Australia despite repeated calls for certainly and predictability. Continue reading
Top 5 – Health Items in the 2013 Budget
We look a little deeper into the Budget papers to find the Top 5 Health announcements. Continue reading
Industry Insight – TGA Blueprint
Regardless of the type of therapeutic good you commercialise – original brand medicine, generic medicine, biological or medical device – we all share the common challenge of operating in a heavily regulated market. Therefore the role of the TGA in approving these products for market entry and maintaining marketability is paramount for commercial success in the pharmaceutical and medical device industry. In this Industry Insight we see how the TGA’s Blueprint reforms stack up and look at the impact on industry. Continue reading
People Trends – Turnover at the top reflects industry broadly
In a media release last month, Medicines Australia announced the resignation of its Board Chair, Mark Masterson. When we consider the recent turnover of MA board members does this turnover at the top reflect what is going on in the industry more broadly? Continue reading
Election Watch 2013
In January, the Prime Minister stated she was “not starting the nation’s longest election campaign.” What she has started however, is a very long period of political lobbying from the pharmaceutical and healthcare industry. Continue reading
Top 5 – Hot Topics Affecting Industry
Commercial Eyes holds a unique place as trusted advisers in the Australian pharmaceutical and medical device industries. We are often asked for advice in navigating the market forces that affect how our clients conduct their businesses. So, here are the top 5 hot topics our clients are seeking advice on in 2013. Continue reading
